KVUE Kenvue Inc: Rasio nilai perusahaan marang pendapatan

Logo perusahaan publik Kenvue Inc (KVUE)

The stability of the external environment and the neutral status of its products ensure sustainable growth for Kenvue Inc. (KVUE), as confirmed by the company's current price-to-sales ratio on GURU.Markets. The value of 2858.47 reflects the metric's balance, drawing on years of trust in the quality of pharmacy brands. The business foundation is built on the daily habits of families who have integrated iconic care products into their routines.

Kenvue Corp (KVUE) - Nilai perusahaan marang pendapatan saka 23.11.2025 nganti 14.11.2026

Rincian metrik keuangan lan pasar Kenvue Corp (KVUE)

- rega lan prakiraan konsensus rega:
Pambiji fundamental perusahaan:KVUE (kenvue.com)
Barang utama Kenvue Inc

For Kenvue Inc. (KVUE), the historical EV/Sales level serves as a tool for assessing the market value of the business relative to sales volumes, excluding the impact of leverage. This metric compares the total enterprise value to revenue, allowing for the identification of fundamental overvaluation or undervaluation of the asset during periods of market volatility. For a company with a high proportion of outsourced production and logistics, this indicator is critical, as it reflects the efficiency of brand monetization while minimizing capital expenditures.

Analisis pesaing

HLN: Rasio nilai perusahaan marang pendapatan|Verona Pharma (VRNA) - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Jyong Biotech Limited (MENS)|LGND (Ligand Pharmaceuticals Incorporated) - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Amneal Pharmaceuticals Inc AMRX|Multiplikator EV/Sales PRGO|Koefisien nilai perusahaan marang pendapatan ALVO|Multiplikator EV/Sales LQDA (Liquidia Technologies)|Multiplikator EV/Sales Galapagos GLPG|ANI Pharmaceuticals Inc - Multiplikator EV/Sales|MNKD (MannKind Corp.) - Rasio nilai perusahaan marang pendapatan|AMPH: Multiplikator EV/Sales|PCRX (Pacira BioSciences) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan ARS Pharmaceuticals Inc|Nilai perusahaan marang pendapatan Theravance Biopharma, Inc. (TBPH)|Nilai perusahaan marang pendapatan AQST (Aquestive Pharma)|SCPH - Multiplikator nilai perusahaan marang pendapatan|Multiplikator EV/Sales TECX (Tectonic Therapeutic, Inc.)|TNXP - Nilai perusahaan marang pendapatan|China SXT Pharmaceuticals, Inc. - Multiplikator EV/Sales|EPRX - Multiplikator EV/Sales|BHST: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan eXoZymes Inc (EXOZ)|ORMP (oramed.com) - Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan ENTX (Entera Bio)|Rasio nilai perusahaan marang pendapatan MindWalk (HYFT)|Multiplikator EV/Sales ABVC BioPharma, Inc. (ABVC)|Rasio nilai perusahaan marang pendapatan Cumberland Corp CPIX|QNTM - Nilai perusahaan marang pendapatan|FGEN - Rasio nilai perusahaan marang pendapatan|TELO - Multiplikator EV/Sales|Rani Therapeutics Inc (RANI) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan SNYR|Rasio nilai perusahaan marang pendapatan Rallybio Corp|Rasio nilai perusahaan marang pendapatan LEXX|Multiplikator EV/Sales PULM|PTHL: Nilai perusahaan marang volume dodolan|Multiplikator EV/Sales APM (Aptorum Group Ltd)|LYRA - Nilai perusahaan marang pendapatan|Impact BioMedical Inc - Multiplikator EV/Sales|Nilai perusahaan marang volume dodolan TNFA|YCBD (cbdmd.com) - Nilai perusahaan marang pendapatan|painreform.com - Nilai bisnis marang pendapatan|Nilai perusahaan marang pendapatan CYTO|Rasio nilai perusahaan marang pendapatan LIPO|Rasio nilai perusahaan marang pendapatan optinose.com (OPTN)|PIRS (Pieris Pharma) - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Procaps Group S.A. PROC|Rasio total nilai perusahaan marang pendapatan petrospharma.com (PTPI)|QLI - Rasio nilai perusahaan marang pendapatan|Nilai bisnis marang pendapatan SLRN (ACELYRIN)|TFF Pharmaceuticals, Inc (TFFP) - Rasio nilai perusahaan marang pendapatan